Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
International trial aims to prevent Alzheimer’s in high-risk young adults

International trial aims to prevent Alzheimer’s in high-risk young adults

NTU spin-off teams up with Osler Group to offer early dementia detection tool

NTU spin-off teams up with Osler Group to offer early dementia detection tool

Technology improves caregiver experience for families dealing with dementia

Technology improves caregiver experience for families dealing with dementia

Alzheimer’s disease may leave early signs in the gut, study finds

Alzheimer’s disease may leave early signs in the gut, study finds

Alzheimer's disease linked to disrupted brain oxygenation and neuronal function

Alzheimer's disease linked to disrupted brain oxygenation and neuronal function

Does COVID increase the risk of Alzheimer’s disease?

Does COVID increase the risk of Alzheimer’s disease?

Lifelong exercise linked to lower dementia risk

Lifelong exercise linked to lower dementia risk

X-ray tomography reveals the gut-brain connection in Alzheimer's

X-ray tomography reveals the gut-brain connection in Alzheimer's

Drawn-out overhaul of troubled Montana hospital leaves lawmakers in limbo

Drawn-out overhaul of troubled Montana hospital leaves lawmakers in limbo

New study compares dementia care approaches and the impact on caregivers

New study compares dementia care approaches and the impact on caregivers

University of Oklahoma researcher leads efforts to unravel mysteries of cognitive decline

University of Oklahoma researcher leads efforts to unravel mysteries of cognitive decline

Prolonged REM sleep latency linked to Alzheimer’s disease biomarkers

Prolonged REM sleep latency linked to Alzheimer’s disease biomarkers

Discovery could contribute to the development of new drugs for transthyretin amyloidosis

Discovery could contribute to the development of new drugs for transthyretin amyloidosis

Study links oral microbiome to cognitive function in older adults

Study links oral microbiome to cognitive function in older adults

New diagnostic guidelines aim to distinguish common memory disorder from Alzheimer’s

New diagnostic guidelines aim to distinguish common memory disorder from Alzheimer’s

Hebrew SeniorLife's Wolk Center achieves level 2 Age-Friendly Health System status

Hebrew SeniorLife's Wolk Center achieves level 2 Age-Friendly Health System status

Crick researchers identify key Y chromosome genes influencing sperm development

Crick researchers identify key Y chromosome genes influencing sperm development

Diagnostic guidelines released for limbic-predominant age-related TDP-43 encephalopathy

Diagnostic guidelines released for limbic-predominant age-related TDP-43 encephalopathy

Childhood epilepsy linked to late-onset brain amyloid disorders

Childhood epilepsy linked to late-onset brain amyloid disorders

Breakthrough discovery sheds light on how brain cells activate learning genes

Breakthrough discovery sheds light on how brain cells activate learning genes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.